Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Ebell et al, 2000, U.S.A | 9 studies which were large, blinded prospective studies containing over 300 patients with sore throat. The studies were required to note history and physical examination data and used throat culture as a reference standard. The aim was to identify patients with Group A B-haemolytic streptococcal infection. | Systematic review, including 9 relevant randomised controlled trials. 1++ evidence. | Likelihood ratio of one aspect of clinical examination detecting presence of GABHS | Tonsillar exudate (LR+=3.4) pharyngeal exudate (LR+=2.1) strep throat exposure in previous 2 weeks (LR+=1.9). The absence of symptoms was not efficient at ruling out the disease. | The accuracy of clinical prediction rules in the different studies is presented in different statistical forms making it difficult to compare. Centor's score has not been validated in younger patients |
Most valid clinical prediction rules | Area under ROC curve 0.79(good accuracy) | ||||
Schwartz et al, 1998, Austria | A convenience sample of 192 patients aged 1 to 18 years who presented to a private peadiatric office with signs and symptoms of acute pharyngitis. A clinical examination was undertaken followed by a rapid antigen detection test and also a throat swab. | Diagnostic study | Pharyngeal findings of patient group with GABS compared to those without | Pharyngeal erythema 95% with vs 80% without. Palatal enanthem 44% v 10%. uvular erythema or petechiae 71% v 37%, uvular enanthem37% v 17%, Uvular oedema 69% v 50%, tonsillar erythema 77% v 55%, tonsillar exudate 75% v 38%( all p values less than 0.01 no specific figures given) | We are not told how the patients were chosen for the study (if it was all suitable patients or just some) We are not specifically told if the examiner was blind to the results of the rapid antigen detection test. This study only includes children and is not validated in adults |
Hjortdahl P, Melbye H, 1994, Norway | 174 patients who presented to the Emergency Department. Patients were required to be 18 years or older, attending between 16.00 and 21.00 with the chief complaint of a sore throat. Clinical examination was carried out and the doctor was required to complete a visual analogue scale about their degree of certainty of presence or absence of GABHS. Blood samples and throat swabs were taken. GABHS was diagnosed if a postive GABHS culture was found or a four fold or more increase or fall of AST or ADNase B serum during a 4 week observation period. | Diagnostic study | Number of incorrect diagnoses | 1 in 3 | Bias may be introduced because 40 different doctors of differing experience examined the patients. Only patients attending between 4 and 9 pm were seen. The prevalence of GABHS was quite high in this population (34%) this may be higher than in the UK and so the sbility to generalise this study may be affected. It is debatable whether the inclusion of patients with a negative culture but a four fold or greater change in AST or ADNase B serum titre ,into the GABHS diagnosed group is appropriate. |
Fair degree of certainty of clinical diagnosis that the patient did not have GABS | Correct in 53/67 cases. True negative rate 79% | ||||
Fair degree of certainty that the patient does have GABHS | Correct in 21/33. True positive rate 64% | ||||
Correct identification of GABHS by clinical evaluation alone vs identification by immunological assay | 38/59 (sensitivity 0.64) 40/56 (sensitivity 0.71) | ||||
sSnsitivity of clinical examination vs immunological assay | Sensitivity 0.64 vs 0.71. Specificity 0.71 vs 0.93. Likelihood ratio 2.2 vs 8.7. postive predictive value 0.52 vs 0.82 | ||||
Nawaz H, Smith DS, Mazhari R, et al 2000 USA | A convenience sample of 218 patients seen for sore throat during business hours on weekdays beween June 1993 and April 1996. No subjects excluded. Clinical data, including clinical predictors of GABHS was recorded on a standardized checklist data form and a throat swab was performed. | Prospective cohort study | Aspects of clinical examination with the highest probability of GABHS | Tender adenopathy and enlarged tonsils and pharyngeal erythema and tonsillar exudates. Postive predictor value 46. Sensitivity 71, specificity 77 | The sample studied was small and of convenience so there could have been selection bias. Some eligible patients were missed. Variation between physicians assessment may have existed. |
Woods WA, Carter CT, Schlager TA 1999 USA | 35 children between 2 and 3 years presenting to the Emergency department with symptoms of a URTI. Pharyngeal signs and symptoms were recorded and throat swabs taken. | Prospective diagnostic study | Clinical findings in GABHS and non-GABHS infection.Fever | GABHS positive 90% and negative 76% | There is no mention of how many of the eligible patients were included in the study. The sample size was too small for comparison of clinical findings in GABHS and non-GABHS so effectively no conclusions can be drawn. |
Tonsillar exudate | 40% vs 28% | ||||
Cervical adenopathy | 60% vs 20% | ||||
Rhinorrhea | 40% vs 60% | ||||
McIsaac WJ, Kellner JD, Aufricht P et al 2004 Canada | 787 children and adults presenting with acute sore throat. Recommendations from 2 guidelines were compared with rapid testing alone, a clinical prediction rule (the modified Centor's score) and treatment for positive throat cultures only. Culture all was the gold standard | Diagnostic study | Culture all | Sensitivity 100%, specificity 100% | This study only included adults and children with a modified Centor score of 2 or more, however most guidelines support the use of clinical scores to to exclude patients. The sensitivity of the rapid test was only 83%. The study was not able to assess the impact of higher or lower GABHS prevalence. |
Children-rapid test all, treat those with positive results, throat culture those with negative strep tests. Adults rapid test all, treat positive results, dont culture negative results | Children 100%, 99%, adults 76.7%, 99.2% | ||||
Children-treat as above. Adults rapid test all with a centor score of 2 or 3 and treat if positive. Treat all adults with a centor score over 4 empirically | Children as above, adults 78.1%, 95.8% | ||||
Treat children as above. test no adults and treat those with a centor score of 3 or 4 empirically | Children as above, adults 76.7%, 43.8% | ||||
Throat culture all with a centor score of 2 or 3.If score of 4 or more treat empirically. | Children 100%, 90.3%. adults 100%, 96.5% | ||||
Rapid test on all children and adults, treat those with positive results without culture confirmation of negative results | Children 85.8%, 99% adults 56% 99.2% |